Article Details
Retrieved on: 2021-06-08 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(“Xeris Biopharma Holdings”). The deal's closing terms allow the Strongbridge shareholders to get 1 non-tradeable CVR for every single ordinary share ...
Article found on: techstockobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here